Oxford Vaccine Group (OVG), which led the rapid clinical development of the Oxford vaccine in COVID-19 in the pandemic, has been awarded a total of £7,788,783 by UK Aid for research into the prevention of five dangerous diseases with epidemic or pandemic potential.
Increased β-amyloid accumulation may be linked to Alzheimer’s dementia risk in oldest of the old
A new study indicates that severity of amyloid deposition in the brain -; not just age -; may be key to determining who will benefit
December 26, 2023